296 related articles for article (PubMed ID: 24241364)
1. The influence of renin-angiotensin system genotypes on the antiproteinuric response to high doses of olmesartan in non-diabetic proteinuric nephropathies.
Goyache-Goñi B; Aranda-Lara P; Reyes-Engels A; Frutos-Sanz MA; Hernández-Marrero D
Nefrologia; 2013 Nov; 33(6):771-8. PubMed ID: 24241364
[TBL] [Abstract][Full Text] [Related]
2. Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms.
Lee YJ; Jang HR; Kim SG; Chae DW; Do JY; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG
Nephrology (Carlton); 2011 Jul; 16(5):502-10. PubMed ID: 21303424
[TBL] [Abstract][Full Text] [Related]
3. Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.
Park HC; Choi HY; Kim BS; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
Kidney Blood Press Res; 2006; 29(4):216-24. PubMed ID: 16960460
[TBL] [Abstract][Full Text] [Related]
4. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
5. The renin--angiotensin system gene polymorphisms and clinicopathological correlations in IgA nephropathy.
Ong-Ajyooth S; Ong-Ajyooth L; Limmongkon A; Tiensingh A; Parichatikanon P; Nilwarangkur S
J Med Assoc Thai; 1999 Jul; 82(7):681-9. PubMed ID: 10511770
[TBL] [Abstract][Full Text] [Related]
6. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.
Zivko M; Kusec R; Galesić K
Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214
[TBL] [Abstract][Full Text] [Related]
7. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV
Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacogenetics of angiotensin system in non diabetic nephropathy].
Coto E; Marín R; Alvarez V; Praga M; Fernández Andrade C; Arias M; Poveda R; Vallés M; Galcerán JM; Luño J; Rivera F; Campistol JM
Nefrologia; 2005; 25(4):381-6. PubMed ID: 16231503
[TBL] [Abstract][Full Text] [Related]
9. Antiproteinuric effect of olmesartan in patients with IgA nephropathy.
Tomino Y; Kawamura T; Kimura K; Endoh M; Hosoya T; Horikoshi S; Utsunomiya Y; Yasuda T; Toyoda M; Tsuge T; Kaneko K
J Nephrol; 2009; 22(2):224-31. PubMed ID: 19384840
[TBL] [Abstract][Full Text] [Related]
10. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.
Ahluwalia TS; Ahuja M; Rai TS; Kohli HS; Bhansali A; Sud K; Khullar M
DNA Cell Biol; 2009 Mar; 28(3):141-50. PubMed ID: 19108684
[TBL] [Abstract][Full Text] [Related]
11. Angiotensinogen T235 and ACE insertion/deletion polymorphisms associated with albuminuria in Chinese type 2 diabetic patients.
Young RP; Chan JC; Critchley JA; Poon E; Nicholls G; Cockram CS
Diabetes Care; 1998 Mar; 21(3):431-7. PubMed ID: 9540028
[TBL] [Abstract][Full Text] [Related]
12. ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1.
Perna A; Ruggenenti P; Testa A; Spoto B; Benini R; Misefari V; Remuzzi G; Zoccali C
Kidney Int; 2000 Jan; 57(1):274-81. PubMed ID: 10620209
[TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease.
Buraczyńska M; Pijanowski Z; Spasiewicz D; Nowicka T; Sodolski T; Widomska - Czekajska T; Ksiazek A
Kardiol Pol; 2003 Jan; 58(1):1-9. PubMed ID: 14502296
[TBL] [Abstract][Full Text] [Related]
14. Population-based case-control study of renin-angiotensin system genes polymorphisms and hypertension among Hispanics.
Bautista LE; Vargas CI; Oróstegui M; Gamarra G
Hypertens Res; 2008 Mar; 31(3):401-8. PubMed ID: 18497458
[TBL] [Abstract][Full Text] [Related]
15. Interaction between gene polymorphisms of renin-angiotensin system and metabolic risk factors in premature myocardial infarction.
Petrovic D; Zorc M; Kanic V; Peterlin B
Angiology; 2001 Apr; 52(4):247-52. PubMed ID: 11330506
[TBL] [Abstract][Full Text] [Related]
16. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
[TBL] [Abstract][Full Text] [Related]
17. [Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes].
Buraczyńska M; Ksiazek P; Łopatyński J; Spasiewicz D; Nowicka T; Ksiazek A
Pol Arch Med Wewn; 2002 Aug; 108(2):725-30. PubMed ID: 12476891
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.
Hunley TE; Julian BA; Phillips JA; Summar ML; Yoshida H; Horn RG; Brown NJ; Fogo A; Ichikawa I; Kon V
Kidney Int; 1996 Feb; 49(2):571-7. PubMed ID: 8821846
[TBL] [Abstract][Full Text] [Related]
19. ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus.
Ha SK; Yong Lee S; Su Park H; Ho Shin J; Jung Kim S; Hun Kim D; Rae Kim K; Yung Lee H; Suk Han D
Nephrol Dial Transplant; 2000 Oct; 15(10):1617-23. PubMed ID: 11007831
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system gene polymorphisms and premature coronary heart disease.
Sekuri C; Cam FS; Ercan E; Tengiz I; Sagcan A; Eser E; Berdeli A; Akin M
J Renin Angiotensin Aldosterone Syst; 2005 Mar; 6(1):38-42. PubMed ID: 16088850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
